nanoSaar AG is the owner of the patented MJR® (MicroJet Reactor) technology.
The MJR® technology can produce emulsions, nano/micro particles, and encapsulations of a precisely defined size.
Our MJR® technology creates superior results compared to high-pressure homogenization, milling, batch processes and other technologies.
A continuous, low-cost production process allows for practically unlimited industrial scale-up.
Our customers benefit from product development services and setup of on-site MJR® production capacity.
Our business strategy is based on licensing and joint venture models.
Gips-Schüle Research Award 2015
German Industry Innovation Award 2016
“Industriepreis” Award 2016
Innovator of the Year 2017
Finalists in the category Start-Up Companies.
Winner in the Category Microsystems Technology.
Innovator of the Year 2017 in the chemical, pharmaceutical & biotechnology sector.
nanoSaar AG, the holding company, is located in Starnberg, Germany. It coordinates our business development and financing activities.
nanoSaar lab GmbH, our laboratory entity, is located in Überherrn, Germany. It conducts all customer projects and its own proprietary product-development projects.
nanoSaar Engineering markets our MJR machines for use in laboratories and on-site at customers’ production facilities.
nanoSaar Licensing is our division, where we negotiate and settle licensing agreements and/or royalties for the exclusive use of our MJR production machines.
nanoSaar Ventures matches our product ideas with strong partners that have proven marketing & sales track records in their respective industries.
Dr. Michael Steiner
More than 30 years of international experience in chemical, consumer, and healthcare industries.
PhD at the Max Planck Institute of Biochemistry in Martinsried near Munich.
Managing Partner with JSB-Partners (Boston/Munich).
Management consulting positions as senior partner and group leader of global Healthcare practice at Bain & Company (New York City) and The Boston Consulting Group (Munich/Boston).
Co-founder of the venture-capital company MPM Capital (Boston/San Francisco).
Dr. Stefan Hagemann
More than 25 years of international experience in management consulting (The Boston Consulting Group in Munich), private equity (Alchemy Partners in Frankfurt/London), venture capital (TTM Investor in Bonn/Munich), and hedge-fund management (Euvestor AG in Munich).
Focus on business development, M&A, finance, and IPOs in many different industries.
Various positions on executive and supervisory boards—such as CFO—at numerous portfolio companies.
Nano-Additives for Cement & Concrete
Nano Additives for Road Construction
Seed Nanoparticles for Precipitation Processes
Nano-Additives for Lubricants
Mit der MJR Technologie Betriebskosten senken
Video Introduction nanoSaar
Nanoparticles for Solar Cells